CYCC

Q: What is the price of Cyclacel Pharmaceuticals (CYCC) today?

The price of Cyclacel Pharmaceuticals (CYCC) today is R$ 32,03, with a variation of -94.76% compared to the last year. The price of Cyclacel Pharmaceuticals (CYCC) started the year trading around R$ 2,00 and today it is at R$ 32,03. Follow the real-time price chart, the historical price of Cyclacel Pharmaceuticals (CYCC), and stock data from Ibovespa and international markets.

Q: When does Cyclacel Pharmaceuticals (CYCC) pay dividends?

Cyclacel Pharmaceuticals (CYCC) did not distribute dividends in the last year.

Q: Cyclacel Pharmaceuticals (CYCC) is it worth it?

Currently, Cyclacel Pharmaceuticals (CYCC) is priced at R$ 32,03, with a P/E of -2,47%, representing a deviation of -766,08% from its historical average P/E. In the last year, the stock showed a variation of -94.76% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 505,62%. The total shareholder return was -94,76%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Cyclacel Pharmaceuticals (CYCC)?

Investing in stocks of Cyclacel Pharmaceuticals (CYCC) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Cyclacel Pharmaceuticals (CYCC) yield today?

The yield of Cyclacel Pharmaceuticals (CYCC) was -24,28% in the last month, -94,76% in the last year and -99,90% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,80 in dividends, um Dividend Yield de 505,62%.If you wanted to buy 100 stocks of Cyclacel Pharmaceuticals (CYCC) today, the total investment would be R$ 3.202,64, based on the current price of R$ 32,03.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 167,82In 5 years: R$ 3,20In 10 years: 0,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Cyclacel Pharmaceuticals Inc.

Price

US$ 6,02

variation (12m)

-94,76%

p/l

-2,47

p/vp

3,92

DIVIDEND YIELD

505,62%

price CYCC

BVMF

CYCC

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of CYCC

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-24,28%

3 months

17,69%

1 year

-94,76%

2 years

-98,90%

5 years

-99,90%

10 years

-100,00%

real profitability

profitability minus inflation.

1 month

-24,28%

3 months

17,51%

1 year

-94,99%

2 years

-98,99%

5 years

-99,93%

10 years

-100,00%

Indicators CYCC

check out the fundamentals of Cyclacel Pharmaceuticals shares

P/E

-2,47

Sector: -3,13 Industry: -3,13

P/SALES RATIO (PSR)

Sector: -4,30 Industry: -4,30

P/BV

3,92

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

505,62%

Sector: - Industry: -

ROA

-131,14%

Sector: -63,35% Industry: -63,35%

ROE

-158,95%

Sector: -70,25% Industry: -70,25%

ROIC

-11.346,24%

Sector: -2.087,51% Industry: -2.087,51%

NET MARGIN

0,00%

Sector: -41,74% Industry: -41,74%

GROSS MARGIN

0,00%

Sector: 38,44% Industry: 38,44%

OPERATING MARGIN

0,00%

Sector: -41,04% Industry: -41,04%

P/EBITDA

-1,49

Sector: -3,27 Industry: -3,27

P/EBIT

-1,49

Sector: -3,27 Industry: -3,27

P/ASSET

3,24

Sector: 1,30 Industry: 1,30

BVPS

1,82

Sector: 1,82 Industry: 1,82

EPS

-2,89

Sector: -2,18 Industry: -2,18

EQUITY / ASSETS

0,83

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-9,66%

Sector: - Industry: -

CYCC indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	16,80	5,46	32,50%	2,85%	US$ 428,41 B	27,75%
PFE	14,75	1,52	10,33%	7,16%	US$ 135,70 B	15,13%
ABBV	100,08	-2.728,87	-2.726,81%	3,04%	US$ 376,58 B	6,45%
NVO	14,91	9,39	62,99%	3,07%	US$ 244,01 B	34,74%
MRK	11,76	4,24	36,03%	3,86%	US$ 207,85 B	28,16%
AZN	26,47	5,50	20,79%	1,97%	US$ 246,61 B	16,23%
BMY	18,26	5,38	29,44%	5,32%	US$ 94,02 B	10,71%
GILD	20,32	7,28	35,82%	2,72%	US$ 142,61 B	24,71%
ZTS	24,91	13,25	53,20%	1,30%	US$ 65,95 B	28,00%
HALO	15,89	27,96	175,93%	0,00%	US$ 9,30 B	48,21%
REGN	13,04	1,96	15,06%	0,47%	US$ 58,80 B	31,83%
AMGN	28,48	20,02	70,29%	3,40%	US$ 148,70 B	14,67%
VRTX	27,97	5,90	21,11%	0,00%	US$ 101,39 B	31,22%
MCK	23,96	-102,92	-429,55%	0,40%	US$ 88,82 B	0,97%
ADMA	18,73	9,75	52,03%	0,00%	US$ 3,88 B	43,51%
CAH	26,18	-13,76	-52,54%	1,33%	US$ 36,23 B	0,60%
BIIB	11,98	1,21	10,08%	0,00%	US$ 21,29 B	17,46%

comparison of CYCC with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history CYCC dividend history

current DY: 505,62%

5-year average DY: 0,00%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	29/04/2025	01/05/2025	36,00000000
Dividends	17/07/2016	01/08/2016	540,00000000

ABOUT THE COMPANY Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

28 years

Foundation: 1997

2006

Year of debut on the stock exchange - 19 years

12

Employees

The Company Cyclacel Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 14,24 Milhões, having a net worth of $ 3,63 Milhões.

With a total of 12 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -5,77 Milhões.

As for its main indicators, the Company has a P/E ratio of -2,47, a P/BV ratio of 3,92 and in the last 12 months the dividend yield of CYCC was at 505,62%.

The Company is traded internationally through the ticker CYCC.

Market value

US$ 14,24 Milhões

Net worth

US$ 3,63 Milhões

US$ 3.630.000,00

Assets

US$ 4,40 Milhões

US$ 4.400.000,00

Total Number of Shares

2,00 Milhões

2.000.000

Average Daily Trading Volume

US$ 2,25 Milhões

US$ 2.254.697,45

Sector

Health Care

Industry

Biotechnology

CYCC

CYCC revenue and profits

CYCC results

DRAG THE FRAME TO SEE MORE DATA

CYCC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 711,42 37,91% (12M)

P/L

23,96

0,40%

ROE

-429,55%

P/VP

-102,92

CAH - Cardinal Health

US$ 152,24 37,10% (12M)

P/L

26,18

1,33%

ROE

-52,54%

P/VP

-13,76

JNJ - Johnson & Johnson

US$ 178,06 11,05% (12M)

P/L

16,80

2,85%

ROE

32,50%

P/VP

5,46

MRK - Merck & Co.

US$ 82,81 --25,38% (12M)

P/L

11,76

3,86%

ROE

36,03%

P/VP

4,24

ABBV - AbbVie

US$ 218,34 16,45% (12M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 23,87 --15,01% (12M)

P/L

14,75

7,16%

ROE

10,33%

P/VP

1,52

AZN - AstraZeneca

US$ 79,55 3,81% (12M)

P/L

26,47

1,97%

ROE

20,79%

P/VP

5,50

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 711,42 37,91% (12 M)

P/L

23,96

0,40%

ROE

-429,55%

P/VP

-102,92

CAH - Cardinal Health

US$ 152,24 37,10% (12 M)

P/L

26,18

1,33%

ROE

-52,54%

P/VP

-13,76

JNJ - Johnson & Johnson

US$ 178,06 11,05% (12 M)

P/L

16,80

2,85%

ROE

32,50%

P/VP

5,46

MRK - Merck & Co.

US$ 82,81 --25,38% (12 M)

P/L

11,76

3,86%

ROE

36,03%

P/VP

4,24

ABBV - AbbVie

US$ 218,34 16,45% (12 M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 23,87 --15,01% (12 M)

P/L

14,75

7,16%

ROE

10,33%

P/VP

1,52

AZN - AstraZeneca

US$ 79,55 3,81% (12 M)

P/L

26,47

1,97%

ROE

20,79%

P/VP

5,50

Common Questions

What is the price of Cyclacel Pharmaceuticals (CYCC) today?

The price of Cyclacel Pharmaceuticals (CYCC) today is R$ 32,03, with a variation of -94.76% compared to the last year. The price of Cyclacel Pharmaceuticals (CYCC) started the year trading around R$ 2,00 and today it is at R$ 32,03. Follow the real-time price chart, the historical price of Cyclacel Pharmaceuticals (CYCC), and stock data from Ibovespa and international markets.

When does Cyclacel Pharmaceuticals (CYCC) pay dividends?

Cyclacel Pharmaceuticals (CYCC) did not distribute dividends in the last year.

Cyclacel Pharmaceuticals (CYCC) is it worth it?

Currently, Cyclacel Pharmaceuticals (CYCC) is priced at R$ 32,03, with a P/E of -2,47%, representing a deviation of -766,08% from its historical average P/E. In the last year, the stock showed a variation of -94.76% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 505,62%. The total shareholder return was -94,76%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Cyclacel Pharmaceuticals (CYCC)?

Investing in stocks of Cyclacel Pharmaceuticals (CYCC) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Cyclacel Pharmaceuticals (CYCC) yield today?

The yield of Cyclacel Pharmaceuticals (CYCC) was -24,28% in the last month, -94,76% in the last year and -99,90% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,80 in dividends, um Dividend Yield de 505,62%.

If you wanted to buy 100 stocks of Cyclacel Pharmaceuticals (CYCC) today, the total investment would be R$ 3.202,64, based on the current price of R$ 32,03.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 167,82
In 5 years: R$ 3,20
In 10 years: 0,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CYCC

Cyclacel Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of CYCC

check out the fundamentals of Cyclacel Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, today you would have

current DY: 505,62%

5-year average DY: 0,00%

type

date with

payment date

value

ABOUT THE COMPANY Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Estados Unidos

28 years

2006

12

PROFIT X PRICE CYCC

CYCC results

CYCC cash flow

evolution of assets - CYCC

CYCC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80